ITGAM and neoplasm: Although αPD-1 treatment did not result in an overall increase in the fraction of total BFP expressing monocytes, both treatments resulted in an enrichment CD11b+ over CD11b− monocytes in the interacting portion of monocytes (Fig. 5 A–D), suggesting tumor-interacting CD11b+ monocytes are a hallmark of successful treatment regimen.